» Articles » PMID: 37153586

Effects of the Interactions Between Platelets with Other Cells in Tumor Growth and Progression

Overview
Journal Front Immunol
Date 2023 May 8
PMID 37153586
Authors
Affiliations
Soon will be listed here.
Abstract

It has been confirmed that platelets play a key role in tumorigenesis. Tumor-activated platelets can recruit blood cells and immune cells to migrate, establish an inflammatory tumor microenvironment at the sites of primary and metastatic tumors. On the other hand, they can also promote the differentiation of mesenchymal cells, which can accelerate the proliferation, genesis and migration of blood vessels. The role of platelets in tumors has been well studied. However, a growing number of studies suggest that interactions between platelets and immune cells (e.g., dendritic cells, natural killer cells, monocytes, and red blood cells) also play an important role in tumorigenesis and tumor development. In this review, we summarize the major cells that are closely associated with platelets and discuss the essential role of the interaction between platelets with these cells in tumorigenesis and tumor development.

Citing Articles

Current status and future perspectives of platelet-derived extracellular vesicles in cancer diagnosis and treatment.

Zhuang T, Wang S, Yu X, He X, Guo H, Ou C Biomark Res. 2024; 12(1):88.

PMID: 39183323 PMC: 11346179. DOI: 10.1186/s40364-024-00639-0.


Pancreatic Cancer and Venous Thromboembolism.

Prouse T, Mohammad M, Ghosh S, Kumar N, Duhaylungsod M, Majumder R Int J Mol Sci. 2024; 25(11).

PMID: 38891849 PMC: 11171482. DOI: 10.3390/ijms25115661.


Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.

Ni J, Yao X, Song W, Zhang H, Zhang H, Wang Y Cancer Med. 2024; 13(9):e7214.

PMID: 38686610 PMC: 11058690. DOI: 10.1002/cam4.7214.


Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.

Li X, Zhang Y, Zhu C, Xu W, Hu X, Martinez D BMC Womens Health. 2024; 24(1):38.

PMID: 38218823 PMC: 10787989. DOI: 10.1186/s12905-023-02871-6.


Association between platelet‑to‑lymphocyte ratio and serum prostate specific antigen.

Hu B, Yan M, Huang S, Liang H, Lian W Mol Clin Oncol. 2024; 20(2):10.

PMID: 38213661 PMC: 10777469. DOI: 10.3892/mco.2023.2708.


References
1.
Egan K, Cooke N, Kenny D . Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis. 2014; 31(6):697-704. DOI: 10.1007/s10585-014-9660-7. View

2.
Schwartzkopff F, Petersen F, Grimm T, Brandt E . CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes. Innate Immun. 2010; 18(1):124-39. DOI: 10.1177/1753425910388833. View

3.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

4.
Kruger-Genge A, Blocki A, Franke R, Jung F . Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18). PMC: 6769656. DOI: 10.3390/ijms20184411. View

5.
Arnold C, Gordon P, Barker R, Wilson H . The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses. Immunobiology. 2014; 220(1):10-9. DOI: 10.1016/j.imbio.2014.09.022. View